BackCardinal Health Overview
Cardinal Health, Inc.

Cardinal Health Target Price

Where could CAH trade next? Consensus target price: $270.

Get informed when a big investor buys or sells

+ Follow

Share Price

$235.66

Average Target Price

$270.5014.8% upside

10 analysts in the last 4 months

High: $292 | Low: $248

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Barclays$27516.7% upsideOpen
2026-08-12Morgan Stanley$26512.5% upsideOpen
2026-08-12Evercore ISI$27014.6% upsideOpen
2026-08-12UBS$28018.8% upsideOpen
2026-08-12Wells FargoStephen Baxter$27717.5% upsideOpen
2026-08-12Mizuho SecuritiesSteven Valiquette$2506.1% upsideOpen
2026-08-12Robert W. BairdEric Coldwell$27416.3% upsideOpen
2026-08-11Leerink Partners$29223.9% upsideOpen
2026-07-20UBS$27416.3% upsideOpen
2026-05-01Robert W. Baird$2485.2% upsideOpen
2026-04-08Evercore ISIElizabeth Anderson$2401.8% upsideOpen
2026-03-09Leerink PartnersMichael Cherny$27516.7% upsideOpen
2026-02-24Barclays$2589.5% upsideOpen
2026-02-10Wells Fargo$2568.6% upsideOpen
2026-02-06Morgan Stanley$2558.2% upsideOpen
2026-02-06Robert W. Baird$2526.9% upsideOpen
2026-02-06UBSKevin Caliendo$26010.3% upsideOpen
2026-02-06Mizuho SecuritiesSteven Valiquette$2350.3% downsideOpen
2026-02-05Evercore ISIElizabeth Anderson$26010.3% upsideOpen
2026-01-29Morgan StanleyErin Wright$2454% upsideOpen
2026-01-14Robert W. BairdEric Coldwell$2506.1% upsideOpen
2026-01-13Leerink PartnersMichael Cherny$2401.8% upsideOpen
2026-01-12Mizuho SecuritiesSteven Valiquette$2225.8% downsideOpen
2025-12-08BarclaysGlen Santangelo$2433.1% upsideOpen
2025-11-03Mizuho SecuritiesSteven Valiquette$21010.9% downsideOpen
2025-11-03Jefferies$2206.6% downsideOpen
2025-10-31Evercore ISIElizabeth Anderson$2206.6% downsideOpen
2025-10-31UBS$2206.6% downsideOpen
2025-10-31Robert W. Baird$2321.6% downsideOpen
2025-08-22Argus Research$18919.8% downsideOpen
2025-08-12Leerink PartnersMichael Cherny$18621.1% downsideOpen
2025-08-12JefferiesBrian Tanquilut$15036.3% downsideOpen
2025-06-13Morgan StanleyErin Wright$18123.2% downsideOpen
2025-06-03Wells FargoStephen Baxter$17924% downsideOpen
2025-02-04Argus ResearchKristina Ruggeri$14837.2% downsideOpen
2024-09-23Robert W. BairdEric Coldwell$14040.6% downsideOpen
2024-09-11Argus ResearchDavid Toung$12547% downsideOpen
2024-08-16Deutsche BankGeorge Hill$11949.5% downsideOpen
2024-08-15Evercore ISIElizabeth Anderson$11551.2% downsideOpen
2024-08-15Morgan StanleyErin Wright$11949.5% downsideOpen
2024-08-15Mizuho SecuritiesAnn Hynes$11053.3% downsideOpen
2024-08-15Robert W. BairdEric Coldwell$13741.9% downsideOpen
2024-08-15Wells FargoStephen Baxter$10157.1% downsideOpen
2024-06-11CFRAGarrett Nelson$11152.9% downsideOpen
2024-05-29Robert W. BairdEric Coldwell$12945.3% downsideOpen
2024-05-15Argus ResearchDavid Toung$11551.2% downsideOpen
2024-05-03Robert W. BairdEric Coldwell$12845.7% downsideOpen
2024-04-05Robert W. BairdEric Coldwell$13443.1% downsideOpen
2023-08-15Morgan StanleyErin Wright$9061.8% downsideOpen
2023-04-12Wolfe ResearchTim Anderson$12746.1% downsideOpen

Cardinal Health (CAH) FAQ

Cardinal Health posts a target price of $270. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $270 for CAH means covering analysts, on average, see the stock 14.8% upside of $235.66 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CAH's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cardinal Health's other metric pages and overview cover the third.

Judging Cardinal Health against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in target price easier to interpret. Start with $270 here, then scan peer and history charts to see if the gap is persistent.